ADVI Expert Insights

2024 Election Pharmaceuticals and Biotech Strategic Analytics, Value and Economics

Caitlin Sheetz Shares Insight on Evaluating the Impact of 2025 Healthcare Policies

2024 Election Inflation Reduction Act Pharmaceuticals and Biotech Uncategorized Federal And State Policy

Lindsay Bealor Greenleaf Shares Federal and State Policy Insights and What to Expect in 2025

Uncategorized

ADVI’s Marc Samuels Shares Insights from AVBCC Executive Leadership Roundtable

Uncategorized Strategic Analytics, Value and Economics

ADVI Expert Irina Yermilov Shares Study from AMCP Nexus

ADVI Health Expert Lindsay Bealor Greenleaf Shares Insights from AVBCC

2024 Election Inflation Reduction Act Federal And State Policy

ADVI Expert Lindsay Greenleaf Shares Insights from the Texas Society for Clinical Oncology Conference (TxSCO) Presentation

Cell and Gene Market Access

ADVI Expert Alicia Silver Shares Insights from American Society of Gene & Cell Therapy Policy Summit (ASGCT) Panel

Cell and Gene Inflation Reduction Act Pharmaceuticals and Biotech

Evolving Healthcare Landscape: Cell and Gene Therapy, Part 1

Digital Therapies Digital Therapeutics Reimbursement

Evolving Healthcare Landscape: Reimbursement

Pharmaceuticals and Biotech Federal And State Policy Market Access

PDAB Considerations and Potential Market Access Impacts

Pharmaceuticals and Biotech Federal And State Policy Market Access Pharmaceuticals and Biotech

Evolving Healthcare Landscape: Cell and Gene

ADVI experts Alicia Silver and Anqi Lu discuss the evolving healthcare landscape with a focus on cell and gene through the lens of commercialization, market access, and trending policy issues.

Inflation Reduction Act Federal And State Policy

Introduction to the Inflation Reduction Act